Activity value 80india Buyer&Supplier,Last transaction date:
2026-03-18Address: 11 g industrial area, govindpurabhopal 462021 india
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for hind pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 12 transactions, with a transaction quantity of 3342215 and a transaction weight of 645.
5fba hind pharma
united statesbuyer,they trade on 2019-03-18
492.84%
>
+View All
Products
Total 244
ProductsTransactionsPerDetail
bat 20564.47%>
pharmaceutical 11435.85%>
products 11435.85%>
tablet 10031.45%>
sodium dichloroisocyanurate tablet 6119.18%>
+View All
Hscode rank
Total 68
HSCode NameTransactionsPerDetail
HS 3004901111335.53%>
HS 3004909911134.91%>
HS 380894004012.58%>
HS 29336990103.14%>
HS 2801100082.52%>
+View All
Trading Area
Total 74
AreaTransactionsPerDetail
kazakhstan25014.51%>
united states1005.80%>
sri lanka995.75%>
afghanistan975.63%>
nepal975.63%>
+View All
Port statistics
Total 39
Port NameTransactionsPerDetail
delhi31518.28%>
delhi air1689.75%>
nhava sheva sea innsa11377.95%>
sahar air cargo acc inbom4694.00%>
delhi air cargo523.02%>
+View All
hind pharma is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical,products.
According to the 52wmb.com global trade database, as of 2026-03-18, the company has completed 1723 international trades,
with its main trading regions covering kazakhstan,united states,sri lanka etc.
The core products include HS30049011,HS30049099,HS38089400 etc,
often transported via delhi,port delhi air, port nhava sheva sea innsa1 etc,
and its main trading partners are m/s ip lyubimova-tulyakova yu.a,zamen pharma ltd.,south austral pvt ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hind pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.